Philippe Chambon

Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France.

EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.

EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA.

FeetMe SAS develops insoles that map foot pressure in real time for diabetic patients. Its insoles are made of pressure sensors that allow patients and doctors to visualize a detailed pressure map of the feet, as well as provide warning to patients if a change in the plantar pressure is detected. The company was founded by Julien Mercier and Alexis Mathieu in 2013 and is headquartered in Versailles, France.

Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA.

FeetMe SAS develops insoles that map foot pressure in real time for diabetic patients. Its insoles are made of pressure sensors that allow patients and doctors to visualize a detailed pressure map of the feet, as well as provide warning to patients if a change in the plantar pressure is detected. The company was founded by Julien Mercier and Alexis Mathieu in 2013 and is headquartered in Versailles, France.

Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA.

New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group.

Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France.

Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA.

Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA.

FeetMe SAS develops insoles that map foot pressure in real time for diabetic patients. Its insoles are made of pressure sensors that allow patients and doctors to visualize a detailed pressure map of the feet, as well as provide warning to patients if a change in the plantar pressure is detected. The company was founded by Julien Mercier and Alexis Mathieu in 2013 and is headquartered in Versailles, France.

BioRelix, Inc. engages in the development of antibiotics. The company was founded by Henry Ford, Howard Hughes, Steven Delco, Ronald R. Breaker and Kennth F. Blount in 2005 and is headquartered in New Haven, CT.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.

Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France.

EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation.

Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA.

BioRelix, Inc. engages in the development of antibiotics. The company was founded by Henry Ford, Howard Hughes, Steven Delco, Ronald R. Breaker and Kennth F. Blount in 2005 and is headquartered in New Haven, CT.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation.

BioRelix, Inc. engages in the development of antibiotics. The company was founded by Henry Ford, Howard Hughes, Steven Delco, Ronald R. Breaker and Kennth F. Blount in 2005 and is headquartered in New Haven, CT.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.

BioRelix, Inc. engages in the development of antibiotics. The company was founded by Henry Ford, Howard Hughes, Steven Delco, Ronald R. Breaker and Kennth F. Blount in 2005 and is headquartered in New Haven, CT.

LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France.

Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France.

FeetMe SAS develops insoles that map foot pressure in real time for diabetic patients. Its insoles are made of pressure sensors that allow patients and doctors to visualize a detailed pressure map of the feet, as well as provide warning to patients if a change in the plantar pressure is detected. The company was founded by Julien Mercier and Alexis Mathieu in 2013 and is headquartered in Versailles, France.